Ep Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

Ep Wealth Advisors, LLC

$11.3 Billion
Q3 2024

A detailed history of Ep Wealth Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 53,951 shares of GILD stock, worth $4.78 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

53,951

Previous 47,459 13.68%

Holding current value

$4.78 Million

Previous $3.26 Million 38.88%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $432,302 - $545,263	6,492 Added 13.68%	53,951 $4.52 Million
Q2 2024 Aug 19, 2024	BUY	$63.15 - $72.88 $33,280 - $38,407	527 Added 1.12%	47,459 $3.26 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $38,223 - $46,612	-534 Reduced 1.13%	46,932 $3.44 Million
Q4 2023 Feb 28, 2024	BUY	$73.27 - $83.09 $26,084 - $29,580	356 Added 0.76%	47,466 $3.85 Million
Q3 2023 Nov 22, 2023	BUY	$73.94 - $80.67 $485,046 - $529,195	6,560 Added 16.18%	47,110 $3.53 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $1.48 Million - $1.69 Million	-19,450 Reduced 32.42%	40,550 $3.13 Million
Q1 2023 Jun 05, 2023	BUY	$77.31 - $88.08 $4.64 Million - $5.28 Million	60,000 New	60,000 $4.98 Million
Q4 2022 Jun 12, 2023	SELL	$62.32 - $89.47 $3.28 Million - $4.71 Million	-52,661 Reduced 87.77%	7,339 $630,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $169,927 - $191,389	2,944 Added 56.83%	8,124 $502,000
Q1 2022 May 20, 2022	SELL	$57.92 - $72.58 $23,631 - $29,612	-408 Reduced 7.3%	5,180 $308,000
Q4 2021 Feb 17, 2022	BUY	$64.88 - $73.64 $63,517 - $72,093	979 Added 21.24%	5,588 $406,000
Q3 2021 Nov 23, 2021	SELL	$67.69 - $73.03 $244 Million - $264 Million	-3,608,644 Reduced 99.87%	4,609 $322,000
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $244 Million - $264 Million	3,608,304 Added 72909.76%	3,613,253 $322,000
Q2 2021 Aug 24, 2021	SELL	$63.47 - $69.35 $10,853 - $11,858	-171 Reduced 3.34%	4,949 $341,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $307,200 - $350,515	5,120 New	5,120 $331,000
Q4 2020 Feb 18, 2021	SELL	$56.65 - $64.55 $229,262 - $261,233	-4,047 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$62.1 - $78.08 $9,377 - $11,790	151 Added 3.88%	4,047 $256,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $119,143 - $138,348	-1,647 Reduced 29.71%	3,896 $300,000
Q1 2020 May 18, 2020	BUY	$62.63 - $80.22 $105,969 - $135,732	1,692 Added 43.94%	5,543 $414,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $46,399 - $51,038	-753 Reduced 16.36%	3,851 $250,000
Q3 2019 Nov 18, 2019	BUY	$62.51 - $69.0 $24,628 - $27,186	394 Added 9.36%	4,604 $292,000
Q2 2019 Aug 27, 2019	SELL	$61.87 - $69.38 $63,107 - $70,767	-1,020 Reduced 19.5%	4,210 $284,000
Q1 2019 May 20, 2019	BUY	$62.53 - $70.05 $15,132 - $16,952	242 Added 4.85%	5,230 $340,000
Q4 2018 Feb 19, 2019	SELL	$60.54 - $79.0 $2,300 - $3,002	-38 Reduced 0.76%	4,988 $312,000
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $358,253 - $396,651	5,026 New	5,026 $388,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Account

Ep Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History